Results 221 to 230 of about 3,203 (298)

Free semigroups of large critical exponent

open access: yesJournal of Topology, Volume 19, Issue 3, September 2026.
Abstract For a convergence group equipped with an expanding coarse‐cocycle, we construct finitely generated free subsemigroups, which we call Bishop−−Jonessemigroups$\textit{Bishop--Jones semigroups}$, of critical exponent arbitrarily close to but strictly less than the critical exponent of the ambient group.
Aleksander Skenderi
wiley   +1 more source

Action units of facial expressions in emotional contagion. [PDF]

open access: yesiScience
Celeghin A   +5 more
europepmc   +1 more source

Surface subgroups for cocompact lattices of isometries of H2n$\mathbb {H}^{2n}$

open access: yesJournal of Topology, Volume 19, Issue 3, September 2026.
Abstract We prove the existence of surface subgroups within any cocompact lattice Γ$\Gamma$ in SO(2n,1)$\mathrm{SO}(2n,1)$ for n⩾2$n\geqslant 2$. This result addresses the cases missing from the work of Hamenstädt in 2015, who constructed surface subgroups in cocompact lattices for all other rank‐1 simple Lie groups of noncompact type.
Jeremy Kahn, Zhenghao Rao
wiley   +1 more source

Small RNA mobility and plant virus diseases. [PDF]

open access: yesJ Exp Bot
Elvira-González L   +2 more
europepmc   +1 more source

Invariant Measure and Universality of the 2D Yang–Mills Langevin Dynamic

open access: yesCommunications on Pure and Applied Mathematics, Volume 79, Issue 8, Page 1973-2102, August 2026.
ABSTRACT We prove that the Yang–Mills (YM) measure for the trivial principal bundle over the two‐dimensional torus, with any connected, compact structure group, is invariant for the associated renormalised Langevin dynamic. Our argument relies on a combination of regularity structures, lattice gauge‐fixing and Bourgain's method for invariant measures ...
Ilya Chevyrev, Hao Shen
wiley   +1 more source

The Real‐World Safety Profile of Immune Checkpoint Inhibitors in Melanoma: FAERS Pharmacovigilance Analysis Complemented by Randomized Trial Evidence

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims Melanoma can be effectively treated with immune checkpoint inhibitors (ICIs), but information regarding the risks of treatment‐related adverse events (trAEs), immune‐related adverse events (irAEs), and real‐world adverse events (AEs) is scarce.
Yiwei Chen   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy